Verdence Capital Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Sell
7,790
-254
-3% -$70.3K 0.09% 195
2026
Q1
$2.38M Buy
8,044
+1,961
+32% +$582K 0.14% 152
2025
Q4
$1.66M Buy
6,083
+977
+19% +$265K 0.1% 186
2025
Q3
$1.38M Sell
5,106
-608
-11% -$165K 0.08% 246
2025
Q2
$1.57M Sell
5,714
-853
-13% -$232K 0.11% 192
2025
Q1
$1.74M Sell
6,567
-5,871
-47% -$1.45M 0.13% 169
2024
Q4
$2.89M Buy
12,438
+3
+0% +$690 0.23% 115
2024
Q3
$2.74M Buy
12,435
+195
+2% +$40.4K 0.22% 117
2024
Q2
$2.41M Buy
12,240
+1,672
+16% +$345K 0.21% 125
2024
Q1
$2.28M Sell
10,568
-270
-2% -$56.7K 0.21% 131
2023
Q4
$2.28M Buy
10,838
+1,336
+14% +$285K 0.22% 119
2023
Q3
$1.9M Buy
9,502
+439
+5% +$87.3K 0.21% 132
2023
Q2
$1.68M Buy
9,063
+831
+10% +$154K 0.19% 133
2023
Q1
$1.58M Buy
8,232
+902
+12% +$163K 0.19% 138
2022
Q4
$1.23M Buy
+7,330
New +$1.27M 0.15% 152

Other funds holding CME

Verdence Capital Advisors's CME Position: Q2 2026 in Review

Verdence Capital Advisors reduced its CME Group (CME) stake by 3.2% in Q2 2026, selling an estimated $70.3K and leaving 7,790 shares worth $1.72M. The position accounts for 0.09% of the portfolio, ranked #195.

Verdence Capital Advisors first reported a position in CME in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.89M in Q4 2024. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Verdence Capital Advisors held 7,790 shares of CME Group worth $1.72M as of Q2 2026.
  • Verdence Capital Advisors sold 254 CME Group shares in Q2 2026, an estimated $70.3K.
  • CME Group made up 0.09% of Verdence Capital Advisors's portfolio in Q2 2026, its #195 holding.
  • Verdence Capital Advisors first reported a position in CME Group in Q4 2022 and has held it in 15 quarters since.
  • Verdence Capital Advisors's CME Group position peaked at $2.89M in Q4 2024.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.